- Research works
- 34 ▼ 3% vs 2013–17
- Citations
- 721 21.4 per fractional work
- Top-10% rate
- 11.2% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Kedrion (Italy) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Nursing, 9.4×. Every wedge is a field page.
Which keywords describe research at Kedrion (Italy)?
By fractional works in all years, weighted toward what it does more of than the world: Hemostasis, Gene Therapy, Inflammation, Prophylaxis, Monoclonal Antibodies, Therapeutic Antibodies, Factor VIII and Hemophilia.
- Risk Factors
- Blood Transfusion
- Oxidative Stress
- Diagnosis
- Platelets
- Vascular Biology
- Protein Aggregation
- Epidemiology
- Hemophilia
- Therapeutic Antibodies
- Monoclonal Antibodies
- Hemostasis
- Inflammation
- Gene Therapy
- Prophylaxis
- Factor VIII
- Thrombosis
- Biopharmaceuticals
- Recombinant Proteins
- Immune Thrombocytopenic Purpura
- Anemia
- Hemorrhage
- Antithrombotic Therapy
- Treatment
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 24 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 24 words, with their numbers
- Inflammation4▲ 5.0×8 topics
- Hemostasis4▲ 74×3 topics
- Gene Therapy4▲ 41×3 topics
- Monoclonal Antibodies3▲ 60×2 topics
- Prophylaxis3▲ 61×2 topics
- Therapeutic Antibodies3▲ 67×2 topics
- Factor VIII3▲ 444×1 topic
- Hemophilia3▲ 444×1 topic
- Thrombosis3▲ 35×3 topics
- Epidemiology2▲ 1.79×15 topics
- Biopharmaceuticals2▲ 98×1 topic
- Protein Aggregation2▲ 86×2 topics
- Recombinant Proteins2▲ 125×1 topic
- Vascular Biology2▲ 112×2 topics
- Immune Thrombocytopenic Purpura2▲ 169×1 topic
- Platelets2▲ 104×1 topic
- Anemia2▲ 45×3 topics
- Diagnosis2▲ 4.3×9 topics
- Hemorrhage1▲ 57×2 topics
- Oxidative Stress1▲ 2.0×8 topics
- Antithrombotic Therapy1▲ 35×2 topics
- Blood Transfusion1▲ 64×2 topics
- Treatment1▲ 2.8×7 topics
- Risk Factors1▲ 3.3×5 topics
Which research topics does Kedrion (Italy) publish most on?
By volume in 2022–2025: Hemophilia Treatment and Research, Platelet Disorders and Treatments, Blood Coagulation and Thrombosis Mechanisms and SARS-CoV-2 and COVID-19 Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hemophilia Treatment and Research Hematology 0 works
- 2 Platelet Disorders and Treatments Hematology 0 works
- 3 Blood Coagulation and Thrombosis Mechanisms Hematology 0 works
- 4 SARS-CoV-2 and COVID-19 Research Infectious Diseases 0 works
- 5 Trauma, Hemostasis, Coagulopathy, Resuscitation Critical Care and Intensive Care Medicine 0 works
- 6 Iron Metabolism and Disorders Hematology 0 works
- 7 Hemoglobin structure and function Cell Biology 0 works
- 8 Cultural Heritage Materials Analysis Archeology 0 works
- 9 Building materials and conservation Earth-Surface Processes 0 works
- 10 Complement system in diseases Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Kedrion (Italy)'s research output changed?
Output in 2018–2022 was 3% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.